Vito Quaranta

Displaying 1 - 3 of 3


New algorithm calculates drug synergy; initial tests involve melanoma, lung cancer

Drug combinations used for the treatment of non-small-cell lung cancer (NSCLC) and melanoma aren’t as effective as they could be.